Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
30%
Ph phase_3
2
20%
Ph phase_4
3
30%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown1
Withdrawn1
Recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 43 (30.0%)
N/A3 (30.0%)

Trials by Status

unknown110%
withdrawn110%
completed660%
recruiting110%
suspended110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10